Braftovi received accelerated approval with Erbitux and mFOLFOX6 for metastatic colorectal cancer with a BRAF V600E mutation.

Nova Scotia's colorectal cancer screening program sends kits to all Nova Scotians aged 50 to 74 every two years. It is aimed at early detection and prevention. The strategy has inspired copies ...

Delcath System has received clearance from the US Food and Drug Administration (FDA) for an investigational new drug (IND) application to start enrolment in a Phase II trial evaluating its Hepzato Kit ...

application to start enrolment in a Phase II trial evaluating its Hepzato Kit (melphalan/hepatic delivery system) as an add-on treatment in patients with liver-dominant metastatic colorectal ...

Colorectal cancer, also known as bowel cancer, is a cancer formed by uncontrolled cell growth in the colon or rectum (parts of the large intestine), or in the appendix. Genetic analysis shows that ...

Oct. 23, 2024 — Scientists have uncovered a critical link between the overconsumption of red meat and an increased risk of colorectal cancer. Their findings pave the ... Oct. 7, 2024 — Doctors ...

ntu.edu.tw Objective To measure the effects of faecal immunochemical test (FIT) for colorectal cancer (CRC) screening on overall and site-specific long-term effectiveness of population-based organised ...

Colorectal cancer is the third-most common type of cancer around the world. In the earlier stages, it can be tough to catch. The symptoms, like diarrhea, abdominal pain and anemia, can easily be ...

If you have a colorectal disease such as diverticulitis or inflammatory bowel disease (IBD), the treatment may be delivered by a colorectal surgeon or gastroenterologist depending on the severity of ...

One of Nova Scotia's cancer screening strategies may be getting revamped thanks to students at NSCAD University in Halifax. Nova Scotia's colorectal cancer screening program sends kits to all Nova ...